Winton Group LTD Akero Therapeutics, Inc. Transaction History

Winton Group LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$19.87 - $26.24 $324,477 - $428,499	-16,330 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$18.65 - $25.46 $93,790 - $128,038	5,029 Added 44.5%	16,330 $365,000
Q2 2021 Aug 10, 2021	BUY	$24.81 - $32.35 $99,785 - $130,111	4,022 Added 55.25%	11,301 $280,000
Q1 2021 Jul 21, 2021	BUY	$24.04 - $34.19 $174,987 - $248,869	7,279 New	7,279 $211,000

190

73.8M

241K

647K

Ticker AKRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,417,600
Market Cap $1.29B
Description
Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.